$28.46
+0.08 (+0.28%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3.7% upside
Low Target
$22.12
Average Target
$29.51
High Target
$35.27
Current Price
$28.46
Current
$28.46
$28.46
Target
$29.51
$29.51
$22.12
$29.51 avg
$35.27
Scenario Analysis
Bear Case
$22.12
-22.3%
Low target
Base Case
$29.51
+3.7%
Avg target
Bull Case
$35.27
+23.9%
High target
Risk/Reward
1.1x
Balanced
Price in Context
52-Week High
$44.60
-36.2% from high
52-Week Low
$13.50
+110.8% from low
Target vs 52W High
$29.51
-33.8% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-1.27
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |